{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 477314858
| IUPAC_name = [4-[4-(sulfinomethylamino) phenyl] sulfonylphenyl] aminomethanesulfinic acid
| image = Aldesulfonesodium.png
| alt = Skeletal formula of aldesulfone sodium
| width = 240
| image2 = Aldesulfone-sodium-3D-spacefill.png
| alt2 = Space-filling model of the component ions of aldesulfone sodium
<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
| legal_UK = <!-- GSL / P / POM / CD -->
| legal_US = <!-- OTC / Rx-only -->
| legal_status =  
| routes_of_administration = Oral
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound = 69%
| metabolism = [[Liver|Hepatic]]
| elimination_half-life = 3 to 8 hours
| excretion =  
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 144-75-2
| ATC_prefix = J04
| ATC_suffix = BA03
| ATC_supplemental =  
| PubChem = 8954
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB01145
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 8610
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 57OWB0Q221
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D02521
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1200580
<!--Chemical data-->
| C=14 | H=16
| N=2 | O=6
| S=3 | Na=2
| molecular_weight = 404.485 g/mol
| smiles = [Na+].[Na+].[O-]S(=O)CNc1ccc(cc1)S(=O)(=O)c2ccc(NCS([O-])=O)cc2
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C14H16N2O6S3.2Na/c17-23(18)9-15-11-1-5-13(6-2-11)25(21,22)14-7-3-12(4-8-14)16-10-24(19)20;;/h1-8,15-16H,9-10H2,(H,17,18)(H,19,20);;/q;2*+1/p-2
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = AZBNFLZFSZDPQF-UHFFFAOYSA-L
}}
'''Aldesulfone sodium''' (or '''sulfoxone''') is an [[antibiotic]] used in the treatment of [[leprosy]].

Sulfoxone sodium was introduced in Japan in 1948.<ref>{{cite journal | pmid = 12412600 | volume=37 | issue=1 | title=[A 50-year history of new drugs in Japan: the developments of antileprosy drugs and their epidemiological aspects] | year=2002 | journal=Yakushigaku Zasshi | pages=76â€“83}}</ref>

==References==
{{reflist}}

{{Antimycobacterials}}
{{Nucleic acid inhibitors}}

[[Category:Sulfonamide antibiotics]]
[[Category:Organic sodium salts]]


{{antiinfective-drug-stub}}